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Introduction
The tumour microenvironment plays an important 
role in the regulation of cancer cell behavior (Bhowmick 
et al., 2004; Bissell and Labarge, 2005). Recent research 
has also revealed that non-cellular components of the 
microenvironment, the extracellular matrix (ECM), also 
play an important role in tumour progression (Erler et al., 
2009; Levental et al., 2009). ECM promotes integrity, 
proliferation and maintenance of tissue morphology 
and also influences the fundamental characteristics 
of the cell (Hynes, 2009; Lu et al., 2011). Several 
mechanisms regulate the dynamics of ECM including 
synthesis, degradation and remodelling required during 
developmental processes (Page-McCaw et al., 2007) and 
deregulation of these mechanisms can lead to disorganized 
ECM with cellular abnormalities resulting in fibrotic and 
cancer conditions (Cox and Erler, 2011). ECM is also 
responsible for maintaining the polarity and architecture 
of epithelial tissues including mammary gland and the 
loss of polarity due to aberrant ECM dynamics is often 
associated with the cancer progression (Ghajar and Bissell, 
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2008; Akhtar et al., 2009). 
ECM not only provides strong support to the mammary 
gland architecture but also acts as a communicating link 
between the extracellular environment and the epithelial 
cells (Akhtar et al., 2009). The ECM protein profile is 
different in various stages of mammary gland development 
including pregnancy, lactation and involution (Warburton 
et al., 1982; Schedin et al., 2004). During involution, 
the majority of the epithelial cells undergo apoptosis 
followed by ECM remodelling and an irreversible 
change in the mammary gland to a pre-pregnant stage 
(Watson, 2006). This ECM remodelling process is due 
to significant expression of matrix metalloproteinases 
(MMPs) (Green and Lund, 2005) and the expression 
profile of MMPs during involution was found to be similar 
to that of developing mammary gland tumours (Almholt 
et al., 2007). The activation of inflammatory responsive 
elements during involution is highly similar to that of 
the tumour microenvironment and in the wound healing 
process (van Kempen et al., 2003; Schedin et al., 2007). 
Previous studies have indicated that mammary gland 
proliferation is low during lactation and mammary 
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epithelial cells undergo a quiescence stage (Knight and 
Peaker, 1982; Capuco et al., 2003). A recent study from 
our lab has indicated that ECM isolated from different 
phases of lactation provides regulatory signals in-vitro 
to mammary epithelial cells (MECs) so they behave in a 
similar way to that observed at the phase of lactation from 
which the ECM was isolated (Wanyonyi et al., 2013). 
From the studies stated above, there is clear evidence that 
lactating glands show less proliferation and as the ECM 
can govern tumour progression, it would be interesting 
to observe if factors in lactating ECM inhibits metastatic 
and tumourigenic potential on breast and oral cancer cells, 
irrespective of their tumourigenic potential. Hence, the 
present preliminary study addressed whether extracellular 
matrix isolated from mammary gland during lactation 
included factors for inhibiting cell division of breast and 
oral cancer cells. 
Materials and Methods
Animals
BALB/c mice were used and were obtained from 
Monash Animal Services, Melbourne, Australia. The 
experiments were approved by Deakin University Animal 
Ethics Committee. Mammary glands were dissected from 
the lactating mice (day 15). In addition, lactating mice (day 
15) were separated from pups and mammary glands were 
dissected from mice at day 4 of involution. All tissues were 
immediately frozen and stored at -80oC till further use. 
Cell lines
MCF10A was a generous gift from Dr. Patrick 
Humbert, PeterMac Cancer Research Institute, Melbourne. 
Cells were grown as previously described (Bruzzone et 
al., 2014). Briefly cells were maintained in Dulbecco`s 
modified Eagle`s medium (DMEM) and Ham’s F12 
medium containing 10% fetal bovine serum (Life 
Technologies), 20 ng/ml epidermal growth factor, 2 μg/
ml insulin, 0.1 μM hydrocortisone, 100 IU/ml penicillin 
and 100 μg/ml streptomycin. MDA-MB-231 and SCC25 
were obtained from American Type Culture Collection 
(ATCC). MDA-MB-231 cells were cultured in DMEM 
media supplemented with 10% fetal bovine serum, 100 
IU/ml penicillin and 100 μg/ml streptomycin. SCC25 
cells were grown in 1:1 mixture of DMEM and Ham‟s 
F12 media supplemented with 10% fetal bovine serum, 
100 μg/ml streptomycin, 100 IU/ml penicillin and 
400 ng/ml hydrocortisone. DOK cells were purchased 
from the European Collection of Authenticated Cell 
Cultures (ECACC) and the cells were grown in DMEM 
media supplemented with 2 mM glutamine, 5 μg/ml 
hydrocortisone, 10 % fetal bovine serum, 100 IU/penicillin 
and 100 μg/ml streptomycin. All cells were cultured at 
37oC with 5% CO2 conditions. 
External microarray dataset and data analysis
Data analysis was performed using publicly available 
microarray data from the studies as represented in the 
Table 1 (SSD 1). Lactating mammary gland (day 9 and day 
15) and involuting mammary gland (day 4) data files were 
obtained from three individual studies as represented in the 
Table 1. The data considered for the comparative analysis 
from three individual studies used the same array platform 
(Affymetrix MG U74 Aver 2). The CEL files (n=11) were 
normalized using gene spring software (Agilent) by robust 
multi-array average method (RMA). Normalized intensity 
values of late lactation data (day 9 and day 10; n=6) was 
compared to the late involution (day 4; n=5) and the fold 
change values were obtained after employing Benjamin- 
Hochberg multiple testing correction. Genes that were 
differentially regulated were considered with significant 
P-Value <0.01 and with fold change value > 2. 
Extracellular matrix preparation from mammary gland 
tissue
Extracellular matrix (ECM) was isolated from 
mammary gland using a homogenization method 
(O’Brien et al., 2010). Briefly, frozen mammary gland 
tissue was pulverized into fine powder using a mortar 
and pestle containing liquid nitrogen. Homogenization of 
powdered tissue (1 g) was performed in high salt buffer 
(2 ml) composed of 200 μg/ml phenyl methyl sulfonyl 
fluoride (PMSF), 2 mM n-ethylmaleimide (NEM) and 
protease inhibitory cocktail (Sigma). ECM was dialysed 
sequentially to eliminate urea and protease inhibitors. 
Ham’s F12 and M199 (1:1 ratio) media without serum 
was used for the final dialysis of ECM and ECM was 
removed from the dialysis membrane, aliquoted and stored 
at -20oC until use. 
Cell culture on ECM
ECM (40 µL) from lactating and involuting mammary 
gland were coated on to each well of a 96- well plate which 
was incubated at 37oC for 1h. Cells (4 x 103) were seeded 
onto the extracellular matrix for further experimental 
analysis (Figure 1). 
Results
Mammary ECM during lactation inhibits cell proliferation
Cells (MCF10A, DOK, SCC25 and MDA-MB-231) 
grown on the ECM isolated from lactation mammary 
gland (lactation matrix) and involution mammary gland 
(involution matrix) were further analysed for proliferation. 
Cells cultured on plastic for each cell line were also 
considered as a reference. Analysis of cell proliferation 
and viability revealed a significant reduction in cell 
viability at day 1 and 2 of culture in both the cancer 
cell lines, MDA-MB-231 and SCC25, when grown 
on lactation matrix (Figure 2). MDA-MB-231 did not 
show a significant reduction in viable cells on day3 on 
lactation matrix in comparison to day2 but SCC25 cells 
showed significant reduction in viable cells at both time 
points (Figure 2). Cells grown on involution matrix 
showed no growth inhibition and the growth pattern of 
the cells was almost equivalent to that of cells grown 
on plastic (Figure 2). The non-tumorigenic cells, DOK 
and MCF10A, showed no growth in the lactation matrix 
and there was no significant cell death observed (Figure 
2). Although DOK cells showed no change in the cell 
growth on lactation matrix during the first 2 days of 
culture, there was a significant increase in the growth on 
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Lactation ECM induces apoptosis in cancer cells
A significant reduction in cell viability was observed in 
cells grown on lactation matrix from day 1 as shown in the 
Figure 2. Therefore, the SCC25 and MDA-MB-231 cells 
grown on lactation and involution matrix were subjected to 
annexin V staining for the detection of apoptosis. SCC25 
and MDA-MB-231 cells grown on involution matrix 
were stained only with Hoechst dye indicating presence 
of live cells (Figure 5). Both the cancer cell lines grown 
day 3. The cells grown on lactation matrix, involution 
matrix and plastic for 48 h were subjected to live/dead 
cell staining using calcein AM (green) and propidium 
iodide (red). No effective cell death was found in the cells 
grown on involution matrix and plastic (Figure 3A to D). 
Non-tumorigenic cells, DOK and MCF10A, did not show 
significant cell death when grown on lactation matrix 
(Figure 3A and C). In contrast, there was a considerable 
effect on the cell viability of tumorigenic MDA-MB-231 
and SCC25 cells, grown on lactation matrix (Figure 3B 
and D). 
Morphology of the cells cultured on mammary ECM
The morphology of SCC25 and MDA-MB-231 cells 
grown on the lactation matrix were round and the cells 
grown on the ECM isolated from the involution matrix 
had a flat morphology due to cell attachment to the 
plastic as revealed by the actin staining (Figure 4). Actin 
staining also revealed formation of sphere like structures 
by MDA-MB-231 cells (Figure 4) on the lactation matrix.
Figure 1. Schematic Representation of Culture of Cells 
on ECM Extracted from Lactating and Involuting 
Mammary Gland. Each well of a 96 well plate was 
coated with 40 µl of ECM and incubated for 1h at 37oC. 
Cells were seeded on the ECM.
Figure 2. Effect on Proliferation of Cells Grown 
on Lactation Matrix, Involution Matrix and Plastic. 
MCF10A, MDA-MB-231, DOK, SCC25 Cells Grown 
on Lactation Matrix, Involution Matrix and Plastic were 
Measured for Cell Viability Using MTS Reagent on day 
0, day 1, day 2 and day 3 at 490 nm Wavelength. The 
asterisk (*) indicates significant P-Value < 0.05 reduction 
in the cell viability of tumorigenic cells, MDA-MB-231 
and SCC25 cells (Students-t-test). In this experiment, 
biological and technical triplicates were considered for 
the statistical analysis
Figure 3. Live/Dead Cell Staining of Cells Grown on 
Lactation Matrix, Involution Matrix and Plastic Surface 
for 48h. MCF10A (A), MDA-MB-231 (B), DOK (C) 
and SCC25 (D) cells were grown for 48 h on lactation 
matrix, involution matrix and plastic surface. Further 
cells were stained with calcein AM and propidium 
iodide stains. Calcein AM stains live cells (green) and 
propidium iodide stains dead cells (red).
Figure 4. Actin Distribution in the Two MDA-MB-231 
and SCC25 Cell Lines by Fluorescence Microscopy. 
Morphology of the tumorigenic cells, MDA-MB-231 
and SCC25 cells, were observed by actin staining 
using rhodamine-phalloidin reagent (Red) that detected 
distributed actin filaments in the cell body after growing 
cells on lactation and involution matrix for 48 h at 37oC.
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on lactation matrix were apoptotic with the presence of 
early and late apoptotic cells (Figure 5). 
Repression of CEP55 expression in the cells grown on 
lactation ECM
Mammary epithelial cells during lactation showed 
low proliferation and cellular quiescence was observed 
(Capuco et al., 2003) which may result from ECM 
regulation. CEP55 protein is often expressed during 
cytokinesis (van der Horst et al., 2009). SCC25 cells and 
MDA-MB-231 cells grown on lactation and involution 
matrix for 48 h were analysed for CEP55 expression 
using immunofluorescence. Results indicated all cells of 
both tumorigenic cell lines grown on involution matrix 
expressed CEP55 but only a few cells grown on lactation 
matrix showed CEP55 expression (Figure 6A and B).
Microarray data analysis 
External datasets were analysed for the comparison 
of gene expression in late lactation and late involution 
stages of mammary gland in mice. Principal component 
analysis through Gene spring analysis showed a clear 
distinction between the two sample types (lactation 
and involution) considered for comparison (Figure 7). 
Figure 5. Annexin V Staining of Breast and Oral Cancer 
Cells Grown on Lactation (LM) and Involution Matrix 
(IM). SCC25 (oral) and MDA-MB-231 (breast) cancer 
cells were grown on lactation matrix for 24 h and 
annexin V staining was performed. Early apoptotic cells 
were stained with annexin V (green) and nuclei with 
Hoechst dye (blue). Late apoptotic cells were stained 
with annexin V (green) and nuclei with propidium iodide 
(red). Dead cells show no annexin V staining but only 
nuclei staining with propidium iodide (red). Live cells 
only show nuclei staining with Hoechst dye (blue).
Figure 6. Immunofluorescence Analysis of CEP55 
Expression in Cells Grown on Lactation and Involution 
Matrix. MDA-MB-231 (A) and SCC25 (B) cells were 
grown on lactation and involution matrix for 48 h and the 
cells were further analysed for CEP55 expression. Cells 
were treated with rabbit anti-CEP55 primary antibody 
and further anti-rabbit alexafluor 488 seccondary 
antibody was used for detection of CEP55 expression 
(green). Cells were counterstained with Hoechst dye 
(blue). Arrow marks indicate cells without CEP55 
expression.
Figure 7. Principal Component Analysis of Involution 
and Lactation Microarray Datasets. Principal component 
analysis (PCA) was performed using Gene Spring 
software on the sample data sets belonging to lactation 
(blue) and involution data (red) using gene spring 
software.
Figure 8. Growth of SCC25 in-vitro Tumour Spheres in 
Lactation and Involution Matrices. SCC25 cells were 
enriched for formation of spheres on agarose. Spheres 
were then placed on lactation and involution matrices 
and were cultured for 72 h. Spheres were stained with 
Hoechst dye (blue).
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Further analysis using Gene Spring software revealed 
significant differentially regulated genes (1,000) with 
significant P-Value less than 0.01 and fold change greater 
than 2 (Supplementary file 2 (SSD 2)). In addition, the 
gene profile was analysed for the expression of genes 
involved in ECM remodelling and genes promoting 
cellular quiescence using the Database for Annotation, 
Visualization and Integrated Discovery (DAVID 6.7) 
program (Dennis et al., 2003), details of which are 
incorporated in the supplementary file 3 (SSD 3). The 
data analysis that was performed includes whole tissue 
of late lactating and late involuting mammary gland and 
hence the present study focuses on the secretory proteins 
that might have been secreted in the ECM. Most of the 
genes related to ECM remodelling were up regulated in 
involuting mammary gland (Table 2 in SSD 1). Further 
analysis of the genes indicated important inflammatory 
response-promoting genes that were up regulated in 
involuting mammary gland compared to the lactating 
mammary gland (Table 3 in SSD 1). Analysis of the 
genes among the significant differentially regulated genes 
promoting cellular quiescence revealed over expression of 
the QSOX1 gene. This gene is related to cells undergoing 
cellular quiescence (Coppock et al., 2000) and was up 
regulated in lactating mammary gland (Table 4 in SSD 1). 
The gene for beta actin (ACTB) expression was found to 
be down regulated and epidermal growth factor (EGF) was 
up regulated in lactating mammary gland in comparison 
to the involuting mammary gland (Table 4 in SSD 1). 
Growth of in-vitro tumour spheres on the lactation and 
involution matrices
Spheres were produced from SCC25 cells as described 
in the supplementary file SSD 1. Spheres grown on 
the ECM from lactating mammary gland did not show 
attachment to the plastic whereas the spheres grown on 
the involution matrix attached to the plastic (Figure 8).
Discussion
Extracellular matrix (ECM) is the major part of the 
epithelial cell microenvironment and plays a major role in 
controlling the cellular behavior, adhesion, proliferation, 
differentiation, migration and apoptosis (Hynes, 2009). 
Changes in ECM composition lead to modification of 
ECM dynamics thereby resulting in the altered tissue 
architecture (Lopez et al., 2008; Engler et al., 2009). 
Mammary gland is emerging as a powerful model to 
investigate the mechanoinduction of the signals induced 
by ECM that can lead to the changes in cellular behavior 
further affecting the tissue. Previous studies indicated that 
cell proliferation in the mammary gland is low during 
lactation and most of the mammary epithelial cells are 
quiescent (Knight and Peaker, 1982; Capuco et al., 2003). 
An earlier study indicated that mammary epithelial cells 
(MECs) grown on the mammary ECM of a specific phase 
of lactation behave and respond like cells belonging to 
the phase of ECM irrespective of the phase of lactation 
from which the MECs were isolated (Wanyonyi et al., 
2013). This is consistent with the conclusion that ECM 
plays a major role in promoting cellular quiescence during 
lactation. This preliminary study has explored the effects 
of lactation matrix on the growth of non-tumorigenic and 
tumorigenic oral and breast cancer cells. 
Lactation matrix promotes cellular quiescence in all cell 
types and induces apoptosis in tumour cells
In the current study, tumorigenic cells (SCC25 and 
MDA-MB-231) and non-tumorigenic cells (MCF10A 
and DOK) demonstrated considerable proliferation when 
cultured on involution matrix, most likely due to the cells 
being able to penetrate the matrix and reach the plastic 
underneath. In contrast, there was no growth observed 
when the cells were cultured on lactation matrix which 
did not allow the cells to penetrate, consistent with 
previous findings that lactation matrix promotes cellular 
quiescence (Capuco et al., 2003). It was observed that 
some of the tumorigenic cells showed cell death when 
cultured on lactation matrix. The presence of factors in 
the mammary ECM during lactation may promote cell 
death only in tumorigenic cells and/or lack of the factors 
essential for the tumorigenic cell survival may induce 
apoptosis in these cells (Elmore, 2007). Actin staining 
revealed cells cultured on lactation matrix showed a 
rounded shape and were unable to penetrate the matrix and 
attach to the plastic surface whereas the cells cultured on 
the involution matrix were able to penetrate and attach to 
the plastic. In addition, enriched SCC25 tumour spheres 
did not attach to the plastic when cultured on lactation 
matrix but did attach to plastic following culture on 
involution matrix. Analysis of microarray data revealed 
over expression of epidermal growth factor (EGF) gene 
in lactating mammary gland compared to involuting 
mammary gland. An earlier study revealed EGF induced 
detachment of cells from the extracellular matrix (ECM) 
and induced dephosphorylation of focal adhesion kinase 
(FAK) reducing the cell attachment and motility (Lu et 
al., 2001). The mammary matrix from lactating gland has 
retained EGF that has been sequestered to ECM to reduce 
the cell attachment. Tissue inhibitor of metalloproteinases 
(TIMPs) inhibit the activity of MMPs (Bourboulia and 
Stetler-Stevenson, 2010) and the current microarray 
analysis did not show any significant over expression of 
TIMPs in lactating mammary gland suggesting that there 
might be other factors in the mammary ECM that block 
the cells to penetrate and attach to the plastic surface. 
Reduction of cytokinesis marker expression, CEP55, in 
tumour cells grown on lactation matrix
Centrosomal protein 55kDa, CEP55, is a cell 
division marker (van der Horst et al., 2009) and is often 
overexpressed in several types of cancers including oral 
and breast cancers (Inoda et al., 2009; Waseem et al., 
2010). When grown on involution matrix, SCC25 and 
MDA-MB-231 cells expressed CEP55 protein but on 
lactation matrix only few cells expressed CEP55 which is 
consistent with the fact that cancer cells require survival 
signals for their proliferation (Elmore, 2007). Earlier study 
showed that breast cancer cells mixed with mammary 
involuting ECM further increases tumorigenicity 
(McDaniel et al., 2006) and it would also be interesting 
to perform these tumorigenic experiments by mixing the 
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tumour cells with mammary ECM from lactating tissue. 
This will clearly suggest whether the mammary ECM 
during lactation has any capacity to inhibit the growth of 
the cancer cells in- vivo. 
Genes promoting ECM remodeling and inflammatory 
genes in involution
In the current microarray data analysis, over expression 
of genes related to chemokines and several inflammatory 
response mediators and over expression of genes related 
to ECM remodeling (matrix metalloproteinases), cysteine 
proteinases, ECM components, cell surface receptors 
were observed in involuting mammary gland. The present 
analysis correlates with previous studies indicating 
involution matrix undergoes ECM remodeling and induces 
an inflammatory response which is similar to the cancer 
microenvironment (van Kempen et al., 2003; Green and 
Lund, 2005; Almholt et al., 2007; Schedin et al., 2007). 
Lactation matrix did not allow the cells to penetrate and 
it has further promoted cell death in the tumorigenic cells. 
However, an important question remaining to be addressed 
is what limits the cells from penetrating the matrix. In 
contrast, involution matrix might lack these factors and 
hence the cells can penetrate and attach to the plastic 
surface. A comparison of these 2 matrices will potentially 
provide this information. 
Cell quiescence promoting gene, QSOX1, may play a 
prominent role in controlling the cell proliferation
Cellular quiescence is one of the prominent features 
of the mammary epithelial cells during lactation (Capuco 
et al., 2003). Earlier studies indicated that laminin-1 
promoted cellular quiescence (Spencer et al., 2011) but 
it was also observed in other studies that there was no 
change in the expression of the laminin during several 
stages of mammary gland development (Woodward et al., 
2001; Schedin et al., 2004). Differential expression of the 
laminin-1 gene was not observed in lactating mammary 
gland in comparison to the involuting mammary gland 
which is consistent with the earlier studies (Woodward 
et al., 2001; Schedin et al., 2004). Further the current 
microarray analysis showed beta actin (ACTB) levels in 
lactation mammary gland were reduced in comparison 
with the involution mammary gland. An earlier study 
indicated that during cellular quiescence, promoted 
by laminin 1 molecule, depletion of nuclear beta actin 
levels were also observed (Spencer et al., 2011). Studies 
have shown nuclear actin is essential for transcriptional 
activity and chromatin arrangement during cell division 
(Lenart et al., 2005). Microarray data analysis also 
revealed significant up regulation of QSOX1 gene in 
lactation mammary gland (in comparison to involution 
mammary gland). QSOX1, an extracellular protein, plays 
an important role in the promotion of cellular quiescence 
and was inversely correlated with the aggressiveness of 
the breast tumours (Pernodet et al., 2012). Recent studies 
suggested that QSOX1 is essential for the incorporation 
of laminin into the extracellular matrix and blocking 
QSOX1 leads to reduced cellular adhesion and migration 
(Ilani et al., 2013). From these observations it is clear that 
over expression of QSOX1 might play a role in recruiting 
laminin into the ECM of lactating mammary gland for 
promoting cellular quiescence. To our knowledge, the 
complete profile of ECM composition at different stages of 
mammary gland development (pre-pregnancy, pregnancy, 
lactation and involution) has not been determined. 
However, in the current study the question remains as 
to why the cells were unable to divide on matrix from 
lactating mammary gland. The plausible explanation 
might be attributed to the local factors in the mammary 
gland (Sinowatz et al., 2000). Further studies to identify 
the ECM proteins might be beneficial to better understand 
role of these proteins and their function. 
Collectively, the current study has provided basic 
insights into the importance of lactation matrix to reduce 
proliferation of oral and breast cancer cells. However, a 
comprehensive identification of the ECM components 
and their potential signaling mechanisms may provide 
strategies for developing novel therapeutic interventions 
for cancer treatment. Unravelling the factors in the 
lactating mammary matrix that induces cell death only 
in the tumorigenic cells might provide new strategies in 
tissue engineering for cancer patients that have undergone 
surgical tissue excision. 
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